In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse

被引:66
作者
Barnhart, KT
Pretorius, ES
Timbers, K
Shera, D
Shabbout, M
Malamud, D
机构
[1] Univ Penn, Ctr Med, Ctr Reprod Med & Surg, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Med, Dept Radiol, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Dept Biostat, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA
[6] Biosyn Inc, Philadelphia, PA 19006 USA
关键词
HIV; MRI; microbicide; spermicide; vagina;
D O I
10.1016/j.contraception.2004.06.013
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
A microbicide is designed to coat the vaginal epithelium and prevent transmission of HIV. Complete coverage is desired for optimal protection. In vivo factors affecting coverage have not yet been studied. This randomized crossover trial evaluates the effect of gel volume and patient activity upon vaginal epithelial coating. Gynol II gel was mixed with a magnetic resonance imaging (MRI) contrast agent. Ten women self-inserted, on separate visits, 3 or 5 mL of gel and underwent serial MRI scanning both before and after simulated intercourse. Gel spread was dependent upon time and volume. There was modest spread during the first hour and greater spread 6 h after insertion. Five milliliters of gel resulted in statistically significantly greater coverage immediately following insertion, within the first 30 min and at 6 h after insertion. Simulated intercourse greatly enhances gel spread. After simulated intercourse, the distribution of the gel at each volume was similar. Less leakage of gel was reported with the smaller volume. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:498 / 505
页数:8
相关论文
共 10 条
[1]
Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging [J].
Barnhart, K ;
Pretorius, ES ;
Stolpen, A ;
Malamud, D .
FERTILITY AND STERILITY, 2001, 76 (01) :189-195
[2]
Barnhart K., 1998, VAG MICR FORM WORKSH, P1
[3]
Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract [J].
Barnhart, KT ;
Stolpen, A ;
Pretorius, ES ;
Malamud, D .
HUMAN REPRODUCTION, 2001, 16 (06) :1151-1154
[4]
Estimates of the incidence and prevalence of sexually transmitted diseases in the United States [J].
Cates, W .
SEXUALLY TRANSMITTED DISEASES, 1999, 26 (04) :S2-S7
[5]
Do spermicides containing nonoxynol-9 prevent sexually transmitted infections?: A meta-analysis [J].
Cook, RL ;
Rosenberg, MJ .
SEXUALLY TRANSMITTED DISEASES, 1998, 25 (03) :144-150
[6]
HARRISON P, MICR 2002 C ANTW BEL
[7]
Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse [J].
Pretorius, ES ;
Timbers, K ;
Malamud, D ;
Barnhart, K .
CONTRACEPTION, 2002, 66 (06) :443-451
[8]
High-resolution MR imaging of the vagina [J].
Siegelman, ES ;
Outwater, EK ;
Banner, MP ;
Ramchandani, P ;
Anderson, TL ;
Schnall, MD .
RADIOGRAPHICS, 1997, 17 (05) :1183-1203
[9]
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers:: a randomised controlled trial [J].
Van Damme, L ;
Ramjee, G ;
Alary, M ;
Vuylsteke, B ;
Chandeying, V ;
Rees, H ;
Sirivongrangson, P ;
Mukenge-Tshibaka, L ;
Ettiègne-Traoré, V ;
Uaheowitchai, C ;
Karim, SSA ;
Mâsse, B ;
Perriëns, J ;
Laga, M .
LANCET, 2002, 360 (9338) :971-977
[10]
VANVEWIJERT J, 2002, BETA, V15, P23